Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing elagolix to oral contraceptive pills for reducing endometriosis-related pelvic pain; enrollment is ongoing by invitati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elagolix (elagolix)
  • Oral contraceptive pills (combined oral contraceptive)

Snippet

Sponsor: Pak Emirates Military Hospital | Conditions: Endometriosis (Diagnosis) | Phase 4 | Status: ENROLLING_BY_INVITATION